Impact of body mass index on anti-BCMA chimeric antigen receptor T-cell therapy outcomes in multiple myeloma
Abstract: Anti–B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy has transformed treatment of relapsed/refractory multiple myeloma (MM), yet host determinants of efficacy remain poorly defined. Although obesity influences immunotherapy outcomes in numerous cancers, the...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2025-12-01
|
| Ráidu: | Blood Immunology & Cellular Therapy |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S3050597625000156 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|